• 1. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Tetraalkylammonium salts
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Quaternary ammonium salts Tetraalkylammonium salts

Comprehensive Overview of Cholamine Bromide Hydrobromide (CAS No. 2565-56-2): Properties, Applications, and Industry Insights

Cholamine Bromide Hydrobromide (CAS No. 2565-56-2) is a specialized organic compound with significant relevance in pharmaceutical and chemical research. This quaternary ammonium salt is widely recognized for its unique molecular structure, which combines a bromide and a hydrobromide moiety. Its dual functionality makes it a versatile intermediate in synthetic chemistry, particularly in the development of cholinergic agents and other bioactive molecules. Researchers and manufacturers value this compound for its stability, solubility, and reactivity under controlled conditions.

In recent years, the demand for Cholamine Bromide Hydrobromide has surged due to its applications in drug formulation and biomedical research. A growing trend in the pharmaceutical industry is the focus on targeted drug delivery systems, where this compound plays a pivotal role as a cationic surfactant. Its ability to enhance membrane permeability has sparked interest in optimizing nanocarrier technologies, a hot topic in precision medicine. Additionally, its use in ophthalmic solutions aligns with the rising global demand for eye care products, addressing concerns like dry eye syndrome and glaucoma.

The synthesis of CAS No. 2565-56-2 involves a meticulous process to ensure high purity, as impurities can affect its performance in sensitive applications. Analytical techniques such as HPLC and NMR spectroscopy are routinely employed to verify its chemical integrity. Industry professionals frequently search for "Cholamine Bromide Hydrobromide synthesis protocol" or "2565-56-2 solubility data," highlighting the need for accessible technical resources. Furthermore, its compatibility with green chemistry principles is under exploration, responding to the push for sustainable manufacturing practices.

Beyond pharmaceuticals, Cholamine Bromide Hydrobromide finds niche applications in material science, particularly in modifying surface properties of polymers. Its antistatic and biocidal characteristics make it valuable in developing functional coatings. With the increasing emphasis on antimicrobial materials in consumer goods, this compound has gained attention in R&D circles. Searches for "2565-56-2 material compatibility" or "Cholamine Bromide in coatings" reflect this interdisciplinary interest.

Quality control of CAS No. 2565-56-2 adheres to stringent regulatory standards, including USP and EP monographs where applicable. The compound's hygroscopic nature necessitates proper storage conditions, a common concern among buyers searching for "Cholamine Bromide Hydrobromide storage guidelines." Suppliers often provide certificates of analysis (CoA) to verify parameters like assay, heavy metal content, and residual solvents, ensuring compliance with Good Manufacturing Practices (GMP).

Emerging studies suggest potential applications of Cholamine Bromide Hydrobromide in neurological research, particularly in modulating nicotinic acetylcholine receptors. This aligns with growing public interest in neurodegenerative disease therapies, as evidenced by search trends for "cholinergic compounds for cognitive health." While still in early stages, such investigations demonstrate the compound's expanding scientific footprint beyond traditional uses.

The global market for 2565-56-2 reflects regional variations in demand, with North America and Europe leading in pharmaceutical-grade consumption, while Asia-Pacific shows growth in industrial applications. Market analysts track queries like "Cholamine Bromide Hydrobromide suppliers 2024" or "CAS 2565-56-2 price trends," indicating the compound's commercial significance. Custom synthesis services have become increasingly popular for researchers requiring derivatized versions of this chemical entity.

From a safety perspective, proper handling of Cholamine Bromide Hydrobromide requires standard laboratory precautions, with Material Safety Data Sheets (MSDS) detailing appropriate personal protective equipment (PPE). Environmental considerations include its biodegradability profile, a frequent subject of regulatory inquiries. The scientific community continues to investigate its structure-activity relationships, particularly how modifications to its quaternary nitrogen center affect biological interactions.

In conclusion, CAS No. 2565-56-2 represents a multifaceted compound bridging pharmaceutical innovation and industrial chemistry. Its evolving applications respond to contemporary challenges in healthcare and advanced materials, while ongoing research uncovers new potential uses. As interest grows in specialty chemicals with precise biological activities, Cholamine Bromide Hydrobromide remains a compound of significant scientific and commercial interest.

• 108-00-9(N,N-Dimethylethylenediamine)
• 142-25-6(N,N,N'-Trimethylethylenediamine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)